Beta Bionics faces a class action lawsuit alleging false statements about the safety and regulatory compliance of its iLet Bionic Pancreas insulin pump. The company claimed FDA concerns were minor and procedural, but the lawsuit reveals serious unreported device issues and injuries. Investors who bought shares between July 30, 2025, and February 24, 2026, are encouraged to join the case before the November 3, 2026 deadline to seek recovery.
Beta Bionics, Inc. is the subject of a securities lawsuit. For readers following the health sector, here is Pluang's market snapshot as of Oct 27, 2026 14:31 WIB: Of 150 priced health-sector US stocks tradable on Pluang, 74 rose and 70 fell today. Notable movers include ACAD at USD 20.28 with a 2.79% increase and 100% buy order activity, MRVI at USD 7.51 up 2.60%, and SANA at USD 2.42 up 2.54% with 65% sell order activity.
Vertex, Inc. has introduced Vertex Sōl™, a connected AI-powered solution that integrates tax and compliance processes across the entire tax lifecycle. This platform links workflows, evidence, and expert-driven AI to provide full transparency and cont...
Roche has received the CE Mark for its new cobas smart e immunoanalyser, a compact device designed to deliver central-lab quality testing in smaller healthcare settings. With over 100 planned assays and rapid reaction times under 18 minutes for most ...
Hong Kong Gold Exchange (HKGX) is integrating Chainlink's Cross-Chain Interoperability Protocol (CCIP) via partners GoldZip and Midas Labs to allow its gold-backed XGZ token to move securely across multiple blockchain networks beyond Ethereum. Each X...
Solana's Firedancer validator client team, led by Jump Crypto, now requires a 1 SOL token burn for each bug report to reduce AI-generated spam. This fee, effective October 18, 2026, discourages low-effort submissions and duplicates, while doubling st...
Bending Spoons announced a proposed offering of $1.5 billion in senior secured notes, split into $1 billion in U.S. dollar notes and approximately $500 million in euro notes, both maturing in 2032. The notes will be issued by two indirect subsidiarie...
